by Elana Gotkine For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE), according to a study scheduled for presentation at the annual meeting of the American Society of Hematology, to be held from Dec. 7 to 10 in San...
Tag: <span>thromboembolism</span>
Post
Diabetes mellitus: Women are at higher risk of venous thromboembolism than men
COMPLEXITY SCIENCE HUB VIENNA IMAGE: PERCENTAGE OF PATIENTS WITH DIABETES MELLITUS (SOLID LINES) DIAGNOSED WITH VTE COMPARED TO PATIENTS WITHOUT DIABETES MELLITUS (DOTTED LINES) WITH VTE (IN %): THE GENDER GAP OF FEMALE (RED LINES) AND MALE PATIENTS (BLUE LINES) SUFFERING FROM VTE IS LARGER IN THE DM COHORT (FEMALE PATIENTS WITH DM) CREDIT: ©...
Post
Rivaroxaban cuts recurrent blood clots in obese patients
(HealthDay)—Real-world evidence shows that rivaroxaban reduces the risk for recurrent venous thromboembolism (VTE) in morbidly obese patients, with similar safety and efficacy as warfarin, according to a study published in the October issue of Thrombosis Research. Alex C. Spyropoulos, M.D., from Northwell Health System in New York City, and colleagues used two U.S. claims databases...